Non-Hodgkin Lymphoma (NHL) is a malignancy that originated in the lymph nodes (glands), which are very important in fighting infections. It was so named in order to distinguish it from Hodgkin's disease, a particular subtype of lymphoma.
Treatment
The treatment to be administered in non-Hodgkin lymphoma is chosen in each case. Depends on several factors, including whether the disease was newly diagnosed or relapsed / relapsed indolent lymphoma is or is aggressive, its stage, the type, the general condition of the patient, their age and their needs and desires.
For many years, the principal treatment of non-Hodgkin lymphoma was chemotherapy. Nowadays, chemotherapy is often combined with therapy with monoclonal antibodies, which sometimes can also be administered separately.
Radiation therapy may be useful when the disease is confined to one or two areas of the body. The high dose chemotherapy is another treatment option for some patients. However, this also destroys the bone marrow, which is to be restored by stem cell transplantation.
Some patients with indolent non-Hodgkin lymphoma no symptoms initially and do not require immediate treatment, this approach gives the name of 'watch and wait'.
Before you can start treatment, it is important to determine, beyond its stage, whether the lymphoma is indolent or aggressive. This process involves laboratory tests and a biopsy of the lymph nodes affected. It is preferable to wait until the test results are available before taking final decisions on treatment to administer. It may seem that with these tests is being unnecessarily delay treatment, but any slight delay will be properly compensated for administering the correct treatment.
The patient may have many doubts or questions to ask your health care team about your treatment and the likelihood of success. Instead of trying to remember the questions during the consultation, it is preferable to think of them beforehand.
Treatment options
• Chemotherapy
• Therapeutic monoclonal antibodies
• Therapy with Radiation
• Watch and wait
• Transplant
• Surgery
• Control of symptoms
Prevention
As with other forms of cancer, diets high in fruits and vegetables may have a protective effect against non-Hodgkin lymphomas. Risk factors for development of the disease include impaired immune system and chemical exposure and / or high doses of radiation.
People with weakened immune systems as a result of inherited genetic diseases, immunosuppressive drugs and HIV infection are at increased risk of developing lymphomas. Patients with the Epstein-Barr virus, HTLV 1 and the bacterium Helicobacter pylori (which causes gastric ulcers), have an increased risk for some types of lymphoma.
Exposure to certain chemicals, including pesticides, solvents, fertilizers, herbicides and insecticides have been linked to the emergence of lymphomas in studies of farmers and other groups that are exposed to high levels of these agents.
Treatment
The treatment to be administered in non-Hodgkin lymphoma is chosen in each case. Depends on several factors, including whether the disease was newly diagnosed or relapsed / relapsed indolent lymphoma is or is aggressive, its stage, the type, the general condition of the patient, their age and their needs and desires.
For many years, the principal treatment of non-Hodgkin lymphoma was chemotherapy. Nowadays, chemotherapy is often combined with therapy with monoclonal antibodies, which sometimes can also be administered separately.
Radiation therapy may be useful when the disease is confined to one or two areas of the body. The high dose chemotherapy is another treatment option for some patients. However, this also destroys the bone marrow, which is to be restored by stem cell transplantation.
Some patients with indolent non-Hodgkin lymphoma no symptoms initially and do not require immediate treatment, this approach gives the name of 'watch and wait'.
Before you can start treatment, it is important to determine, beyond its stage, whether the lymphoma is indolent or aggressive. This process involves laboratory tests and a biopsy of the lymph nodes affected. It is preferable to wait until the test results are available before taking final decisions on treatment to administer. It may seem that with these tests is being unnecessarily delay treatment, but any slight delay will be properly compensated for administering the correct treatment.
The patient may have many doubts or questions to ask your health care team about your treatment and the likelihood of success. Instead of trying to remember the questions during the consultation, it is preferable to think of them beforehand.
Treatment options
• Chemotherapy
• Therapeutic monoclonal antibodies
• Therapy with Radiation
• Watch and wait
• Transplant
• Surgery
• Control of symptoms
Prevention
As with other forms of cancer, diets high in fruits and vegetables may have a protective effect against non-Hodgkin lymphomas. Risk factors for development of the disease include impaired immune system and chemical exposure and / or high doses of radiation.
People with weakened immune systems as a result of inherited genetic diseases, immunosuppressive drugs and HIV infection are at increased risk of developing lymphomas. Patients with the Epstein-Barr virus, HTLV 1 and the bacterium Helicobacter pylori (which causes gastric ulcers), have an increased risk for some types of lymphoma.
Exposure to certain chemicals, including pesticides, solvents, fertilizers, herbicides and insecticides have been linked to the emergence of lymphomas in studies of farmers and other groups that are exposed to high levels of these agents.
Nenhum comentário:
Postar um comentário